140 related articles for article (PubMed ID: 21129449)
1. Chronic cocaine administration reduces striatal dopamine terminal density and striatal dopamine release which leads to drug-seeking behaviour.
Lee J; Parish CL; Tomas D; Horne MK
Neuroscience; 2011 Feb; 174():143-50. PubMed ID: 21129449
[TBL] [Abstract][Full Text] [Related]
2. Sprouting of dopamine terminals and altered dopamine release and uptake in Parkinsonian dyskinaesia.
Lee J; Zhu WM; Stanic D; Finkelstein DI; Horne MH; Henderson J; Lawrence AJ; O'Connor L; Tomas D; Drago J; Horne MK
Brain; 2008 Jun; 131(Pt 6):1574-87. PubMed ID: 18487277
[TBL] [Abstract][Full Text] [Related]
3. Cocaine: an in vivo microdialysis evaluation of its acute action on dopamine transmission in rat striatum.
Hurd YL; Ungerstedt U
Synapse; 1989; 3(1):48-54. PubMed ID: 2537539
[TBL] [Abstract][Full Text] [Related]
4. Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens.
Compton DR; Johnson KM
J Pharmacol Exp Ther; 1989 Feb; 248(2):521-30. PubMed ID: 2918468
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of repeated treatment with haloperidol and clozapine on dopamine release and metabolism in the striatum and the nucleus accumbens.
Ichikawa J; Meltzer HY
J Pharmacol Exp Ther; 1991 Jan; 256(1):348-57. PubMed ID: 1703232
[TBL] [Abstract][Full Text] [Related]
6. [3H]dopamine and [3H]serotonin release in vitro induced by electrical stimulation in A9 and A10 dopamine regions of rat brain: characterization and responsiveness to cocaine.
Chen NH; Reith ME
J Pharmacol Exp Ther; 1993 Oct; 267(1):379-89. PubMed ID: 8229765
[TBL] [Abstract][Full Text] [Related]
7. Acute administration of haloperidol enhances dopaminergic transmission.
Lidsky TI; Banerjee SP
J Pharmacol Exp Ther; 1993 Jun; 265(3):1193-8. PubMed ID: 8389855
[TBL] [Abstract][Full Text] [Related]
8. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
LaHoste GJ; Marshall JF
Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
[TBL] [Abstract][Full Text] [Related]
9. Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release.
Hoffmann IS; Talmaciu RK; Cubeddu LX
J Pharmacol Exp Ther; 1986 Aug; 238(2):437-46. PubMed ID: 2942676
[TBL] [Abstract][Full Text] [Related]
10. Prenatal cocaine exposure decreases nigrostriatal dopamine release in vitro: effects of age and sex.
Glatt SJ; Trksak GH; Cohen OS; Simeone BP; Jackson D
Synapse; 2004 Aug; 53(2):74-89. PubMed ID: 15170820
[TBL] [Abstract][Full Text] [Related]
11. Comparing sertindole to other new generation antipsychotics on preferential dopamine output in limbic versus striatal projection regions: mechanism of action.
Hertel P
Synapse; 2006 Dec; 60(7):543-52. PubMed ID: 16952163
[TBL] [Abstract][Full Text] [Related]
12. Acute and chronic corticotropin-releasing factor 1 receptor blockade inhibits cocaine-induced dopamine release: correlation with dopamine neuron activity.
Lodge DJ; Grace AA
J Pharmacol Exp Ther; 2005 Jul; 314(1):201-6. PubMed ID: 15784652
[TBL] [Abstract][Full Text] [Related]
13. Chronic intermittent L-DOPA treatment induces changes in dopamine release.
Lundblad M; af Bjerkén S; Cenci MA; Pomerleau F; Gerhardt GA; Strömberg I
J Neurochem; 2009 Feb; 108(4):998-1008. PubMed ID: 19196428
[TBL] [Abstract][Full Text] [Related]
14. Repeated administration of cocaine alters dopamine uptake and release in the striatum nucleus accumbens.
Clay LH; Mazzio EA; Kolta MG; Soliman KF
Ann N Y Acad Sci; 1998 May; 844():346-55. PubMed ID: 9668692
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneous dopamine neurochemistry in the striatum: the fountain-drain matrix.
Rodriguez M; Morales I; Gomez I; Gonzalez S; Gonzalez-Hernandez T; Gonzalez-Mora JL
J Pharmacol Exp Ther; 2006 Oct; 319(1):31-43. PubMed ID: 16825531
[TBL] [Abstract][Full Text] [Related]
16. Double dissociation of the effects of haloperidol and the dopamine D3 receptor antagonist ABT-127 on acquisition vs. expression of cocaine-conditioned activity in rats.
Banasikowski TJ; Bespalov A; Drescher K; Behl B; Unger L; Haupt A; Schoemaker H; Sullivan JP; Gross G; Beninger RJ
J Pharmacol Exp Ther; 2010 Nov; 335(2):506-15. PubMed ID: 20724485
[TBL] [Abstract][Full Text] [Related]
17. Increased striatal dopamine synthesis is associated with decreased tissue levels of tyrosine.
Bongiovanni R; Young D; Newbould E; Jaskiw GE
Brain Res; 2006 Oct; 1115(1):26-36. PubMed ID: 16934236
[TBL] [Abstract][Full Text] [Related]
18. Withdrawal from continuous or intermittent cocaine administration: changes in D2 receptor function.
King GR; Ellinwood EH; Silvia C; Joyner CM; Xue Z; Caron MG; Lee TH
J Pharmacol Exp Ther; 1994 May; 269(2):743-9. PubMed ID: 8182540
[TBL] [Abstract][Full Text] [Related]
19. Alterations in the dopaminergic receptor system after chronic administration of cocaine.
Alburges ME; Narang N; Wamsley JK
Synapse; 1993 Aug; 14(4):314-23. PubMed ID: 8161369
[TBL] [Abstract][Full Text] [Related]
20. Cocaine modulates allosteric D
Beggiato S; Borelli AC; Borroto-Escuela D; Corbucci I; Tomasini MC; Marti M; Antonelli T; Tanganelli S; Fuxe K; Ferraro L
Cell Signal; 2017 Dec; 40():116-124. PubMed ID: 28923416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
